Skip to content

Leidos

US · LDOS #1114 by market cap Listed 1970
113.55 -3.14 -2.69%
Live - 5344 symbols - heartbeat 111s ago · 2026-10-08 06:06
Pre-market 112.11 -1.27%
After-hours 113.55 0.00%
Overnight 112.87 -0.60%
Market cap
14.25B
P/B
2.70
EPS
11.14
Reader sentiment Are you bullish or bearish on LDOS?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.2 percentage points.

Institutional ownership

Held by institutions
81.02% -0.20pp
Institutions
945 -4
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund67.89%
Hedge Fund3.77%
Public Company3.40%
Private Company2.38%
Government Pension Fund1.46%
Sovereign Wealth Fund1.41%
Individual/Insider0.65%
Family Office/Trust0.29%
Insurance Company0.13%
Other18.64%

Top holders as of 2026-06-30

BlackRock 7.93% · 9.95M sh
Vanguard Capital Management, LLC 7.11% · 8.92M sh
State Street Global Advisors 5.00% · 6.28M sh
Vanguard Portfolio Management, LLC 4.28% · 5.37M sh
Geode Capital Management, LLC 2.93% · 3.67M sh
J.P. Morgan Asset Management, Inc. 2.79% · 3.50M sh
Invesco Capital Management LLC 2.25% · 2.82M sh
First Trust Advisors L.P. 2.21% · 2.78M sh
Dimensional Fund Advisors 1.69% · 2.13M sh
Van Eck Associates Corporation 1.61% · 2.02M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 38 buys · 12 sells

NameRoleStake
Gerard Fasano Group President of Defense Group 0.08%
Harry M. Kraemer Independent Director 0.07%
Noel Geer Independent Director 0.05%
Mary Schmanske Executive VP of Corporate Operations & Chief Corporate Operations Officer 0.05%
Robert Shapard Independent Chairperson 0.05%
Christopher Cage Chief Financial Officer 0.05%
Roy Stevens President of the Intelligence Group 0.04%
Thomas Bell Chief Executive Officer 0.04%
Elizabeth A. Porter President of Health Group 0.04%
Steve Hull Former Chief Information Officer 0.03%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-29 Robert Shapard Independent Chairperson Other Acquisition +5 --
2026-09-29 Harry M. Kraemer Independent Director Other Acquisition +463 --
2026-09-29 Daniel Antal Former Corporate Secretary Other Acquisition +4 --
2026-09-29 Roy Stevens President of the Intelligence Group Other Acquisition +6 --
2026-09-29 Christopher Cage Chief Financial Officer Other Acquisition +92 --
2026-08-31 Gary May Independent Director Open Market Disposition -1,000 $140.85
2026-08-10 Noel Geer Independent Director Open Market Disposition -10,000 $140.59–141.07
2026-08-03 Roy Stevens President of the Intelligence Group Sale to Issuer -4,584 $118.72
2026-08-03 Christopher Cage Chief Financial Officer Sale to Issuer -4,584 $118.72
2026-08-03 Elizabeth A. Porter President of Health Group Sale to Issuer -5,092 $118.72
2026-07-05 Harry M. Kraemer Independent Director Other Acquisition +310 --
2026-06-29 Robert Shapard Independent Chairperson Other Acquisition +6 --
2026-06-29 Harry M. Kraemer Independent Director Other Acquisition +565 --
2026-06-29 Daniel Antal Former Corporate Secretary Other Acquisition +5 --
2026-06-29 Roy Stevens President of the Intelligence Group Other Acquisition +7 --
2026-06-29 Christopher Cage Chief Financial Officer Other Acquisition +113 --
2026-05-07 Noel Geer Independent Director Other Acquisition +1,067 --
2026-05-07 Noel Geer Independent Director Other Derivative Acquisition +1,281 $131.26
2026-05-07 Robert Shapard Independent Chairperson Other Acquisition +1,067 --
2026-05-07 Robert Shapard Independent Chairperson Other Derivative Acquisition +1,281 $131.26

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 06:06:35 · For reference only, not investment advice and not tailored to your situation.